戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ell binding and intracellular trafficking of tetanus toxin.
2 ct mice from challenge with a lethal dose of tetanus toxin.
3 sary component of the receptor mechanism for tetanus toxin.
4 ffected by pretreatment of synaptosomes with tetanus toxin.
5 he complex was insensitive to proteolysis by tetanus toxin.
6 neurotoxin serotypes A, B, and C, as well as tetanus toxin.
7  carboxyl-terminal 34 amino acid residues of tetanus toxin.
8 f protection against a lethal challenge with tetanus toxin.
9 to define the ganglioside-binding domains of tetanus toxin.
10  by unilateral intrahippocampal injection of tetanus toxin.
11 e remaining BoNT serotypes B-G, anthrax, and tetanus toxin.
12 nd ionotropic glutamate receptor blockers or tetanus toxin.
13  or when synaptic transmission is blocked by tetanus toxin.
14  trafficked similarly but not identically to tetanus toxin.
15  with labeling densities similar to those of tetanus toxin.
16 other neurons, similar to the known route of tetanus toxin.
17 radiolabeled GDNF, BDNF, and CT-1 as well as tetanus toxin.
18 E) complexes as judged by its sensitivity to tetanus toxin.
19 nt were protected from lethal challenge with tetanus toxin.
20 lease, as did treatment of the cultures with tetanus toxin (300 ng/ml) to block endogenous neurotrans
21  relative to mice given the control peptide, tetanus toxin-(830-843).
22 he observation that transgenic expression of tetanus toxin, a blocker of neurotransmitter release via
23 5-HT(2A/2C) receptor agonist, was blocked by tetanus toxin, a substance that prevents vesicular neuro
24                                     Although tetanus toxin accumulated rapidly (within 8 h) at presyn
25 ptic transmission of select PVT neurons with tetanus toxin activated via retrograde trans-synaptic tr
26             In contrast to control cultures, tetanus toxin added to fumonisin B(1)-treated cultures d
27                                              Tetanus toxin also inhibits NT-3 release, suggesting tha
28              In addition, CEDE is blocked by tetanus toxin, an inhibitor of regulated exocytosis, and
29  Transient expression of the light chains of tetanus toxin and botulinum toxin A did not disrupt the
30                                       Mutant tetanus toxin and botulinum toxins, which cleave t-SNARE
31               We have studied the effects of tetanus toxin and botulinus toxin A on neurotransmitter
32 ion or alpha-latrotoxin and was inhibited by tetanus toxin and by phenylarsine oxide, a phosphoinosit
33 with BRD937 or BRD847 were solidly immune to tetanus toxin and salmonella.
34 onella expressing TetC are protected against tetanus toxin and virulent salmonella challenge.
35  strain which expresses fragment C (ToxC) of tetanus toxin, and (ii) soluble tetanus toxoid (TT) with
36 g the pE88 plasmid, which encodes the lethal tetanus toxin, and thus a potential target for drug desi
37 e this, we exposed a domain of the microbial tetanus toxin antigen (TTCF) to disrupted lysosomes that
38                                    Using the tetanus toxin antigen, we show that the introduction of
39            To determine which amino acids in tetanus toxin are involved in ganglioside binding, homol
40                                              Tetanus toxin attenuated the response to the second of t
41          We developed a generally applicable tetanus toxin-based method for transgenic mice that perm
42  living motor neurons using a chimera of the tetanus toxin binding fragment (TeNT HC) and a pH-sensit
43                                              Tetanus toxin binds neuronal tissue prior to internaliza
44                                              Tetanus toxin binds specifically to motor neurons at the
45             Cleavage of VAMP2 and VAMP3 with tetanus toxin blocked cAMP-stimulated renin release from
46 zes with synaptophysin, is not detectable in tetanus toxin-blocked cultures.
47             Furthermore, B-cell responses to tetanus toxin but not influenza hemagglutinin in the ART
48 is inhibited by the presynaptic injection of tetanus toxin, but not by an inactive mutant.
49 rminal fragment of synaptobrevin released by tetanus toxin, but not its C-terminal membrane-anchored
50 terize the fraction of fluorescently labeled tetanus toxin C fragment bound to a ganglioside-populate
51            Protein sequencing of proteolyzed tetanus toxin C fragment co-migrating with that band rev
52 n of both native S. aureus enterotoxin B and tetanus toxin C fragment in spiked dilute serum samples.
53 en, Staphylococcus aureus enterotoxin B, and tetanus toxin C fragment in spiked samples.
54 -specific monoclonal antibody fused with the tetanus toxin C fragment was designed and expressed.
55                                         When tetanus toxin C fragment was proteolyzed with clostripai
56 licited by an adenovirus vector encoding the tetanus toxin C fragment when administered as a nasal or
57 ng this ligand, we observed radiolabeling of tetanus toxin C fragment which could be specifically inh
58    Furthermore, LTIIa binding was blocked by tetanus toxin C fragment, which binds to gangliosides GD
59        A recombinant protein consisting of a tetanus toxin C fragment-specific monoclonal antibody fu
60 exposed to either cholera toxin B subunit or tetanus toxin C fragment.
61                  Intramuscular injections of Tetanus Toxin C-fragment (TTc) labeled with Alexa 790 fl
62 mpetitive immunoassay was also developed for tetanus toxin C-fragment by allowing unlabeled and fluor
63 allowing unlabeled and fluorescently labeled tetanus toxin C-fragment compete to bind to a limited fi
64 owth factor, insulin-like growth factor, and tetanus toxin C-fragment.
65  demonstrate that botulinus toxin type B and tetanus toxin cause a decrease in synaptobrevin II immun
66 ibodies, previously found to protect against tetanus toxin challenge and similar to those observed in
67   Complete protection against in vivo lethal tetanus toxin challenge and the induction of Ag-specific
68 60% of the mice in the BRD937 group survived tetanus toxin challenge if they were preimmunized with B
69  induced protective immune responses against tetanus toxin challenge when applied topically at doses
70 tibodies and were protected against systemic tetanus toxin challenge.
71                                              Tetanus toxin cleaved platelet vesicle-associated membra
72                               Serotype C and tetanus toxin did not bind effectively to T-84 cells, no
73  and AA were released solely from neurons as tetanus toxin did not cleave astrocytic synaptobrevin-2,
74                                              Tetanus toxin does block the residual release from perme
75         The vaccines incorporate a domain of tetanus toxin (DOM) fused to a sequence encoding a candi
76 y synthesized with the P30 helper epitope of tetanus toxin, elicited robust LeTx-neutralizing immunit
77 ntigens (beta-galactosidase or fragment C of tetanus toxin) encoded by one plasmid to augment respons
78  Earlier studies implicated a coreceptor for tetanus toxin entry into neurons: a ganglioside binding
79                                              Tetanus toxin entry into vertebrate motorneurons may inv
80                                Unexpectedly, tetanus toxin exposure causes an increase in SNAP-25 imm
81         We find that the axons of individual tetanus toxin expressing reticulospinal neurons have few
82         In stark contrast, myelination along tetanus-toxin-expressing CoPA neuron axons is entirely n
83 anding of the neuronal receptors utilized by tetanus toxin for the initial entry into nerve cells.
84                          Sequence regions of tetanus toxin-forming CD4+ cell epitopes in 8 HLA-dispar
85 s Typhi and Typhimurium to mucosally deliver tetanus toxin fragment C (Frag C) as a model antigen in
86 HSV) were expressed as C-terminal fusions to tetanus toxin fragment C (TetC) in different Salmonella
87 delivery of a recombinant bacterial vaccine, tetanus toxin fragment C (TTFC) was expressed constituti
88 of recombinant Lactococcus lactis expressing tetanus toxin fragment C (TTFC), which is a known immuno
89 nd spinal cord, we generated a soluble IGF-1:tetanus toxin fragment C fusion protein (IGF-1:TTC) as a
90  In contrast, a similar construct expressing tetanus toxin fragment C under control of the constituti
91 response elicited by CVD 908-htrA expressing tetanus toxin fragment C under the control of the redox-
92  neuronal binding fragment of tetanus toxin (tetanus toxin fragment C, or TTC).
93 ic neuronal binding domain of tetanus toxin (tetanus toxin fragment C, TTC) has been used as a vector
94 on for cholera toxin subunit B and 10 nM for tetanus toxin fragment C.
95  bind plasma proteins, an exogenous protein (tetanus toxin fragment C; TTC), and a viral vector (reco
96 tion stems partly from motor neurone loss, a tetanus toxin fragment-C (TTC) fusion protein was create
97 e have used a pathogen-derived sequence from tetanus toxin (fragment C (FrC)) fused to tumor Ag seque
98 s live vectors for delivery of fragment C of tetanus toxin (FrgC).
99                             We conclude that tetanus toxin, GDNF, and BDNF are released from postsyna
100 sis of the dendritic trees revealed that the tetanus toxin group showed a decrease in complexity arou
101  also to be important for the binding of the tetanus toxin H(C) fragment to ganglioside GT1b.
102 e components of the GT1b binding site on the tetanus toxin H(C) fragment.
103 ved X-ray crystallographic structures of the tetanus toxin H(C) fragment.
104                                Consistently, tetanus toxin had no effect on secretion from permeabili
105          The carboxyl-terminal region of the tetanus toxin heavy chain (H(C) fragment) binds to di- a
106 rgin females can be blocked by expression of tetanus toxin in Or65a, but not Or67d neurons, demonstra
107 chaemia on the subsequent development of the tetanus toxin-induced epilepsy was studied, using contin
108 oxin-GVIA), intact vesicle fusion processes (tetanus toxin inhibits), and transmitter-filled vesicles
109                              A small dose of tetanus toxin injected into the rat hippocampus produces
110 ced TNF exocytosis in BMMCs was dependent on tetanus toxin-insensitive vesicle-associated membrane pr
111                 We now find that the v-SNARE tetanus toxin-insensitive vesicle-associated membrane pr
112 ver a period of 3-6 weeks after injection of tetanus toxin into the hippocampus.
113      In close correlation, microinjection of tetanus toxin into the presynaptic neuron produced a blo
114                               The domains of tetanus toxin involved in ganglioside binding are known
115 s physiological effect is also observed when tetanus toxin is expressed in the GFs.
116               We propose that this domain of tetanus toxin is sufficient for ganglioside binding.
117 ereas Hirudo synaptobrevin is proteolyzed by tetanus toxin, its SNAP-25 isoform is resistant to botul
118 egion- and cell-type-selective expression of tetanus toxin light chain (TeLC) and compared the functi
119                          Silencing BPNs with tetanus toxin light chain (TeNT) increases bilateral mas
120 s blocked by both pan-neuronal expression of tetanus toxin light chain (TeTxLC) and by reduction of a
121                We targeted the expression of tetanus toxin light chain (TeTxLC) to single identified
122 or inhibitory (Galpha(i)) Galpha subunit, or tetanus toxin light chain (TNT) in dopamine and serotoni
123 or targeted astrocyte-specific expression of tetanus toxin light chain (to interfere with vesicular r
124 via combinatorial gene expression to deliver tetanus toxin light chain (tox), an inhibitor of vesicul
125 f serotonergic and raphe neurons in mice for tetanus toxin light chain expression, which prevented ve
126 an adenoviral vector to specifically express tetanus toxin light chain in astrocytes) reduced the HVR
127  using Cre-inducible viral expression of the tetanus toxin light chain in male and female PV-Cre mice
128 culum by injecting a viral vector expressing tetanus toxin light chain in male mice.
129 ng neural activity by targeted expression of tetanus toxin light chain or an inwardly rectifying pota
130                         By expressing either tetanus toxin light chain or diphtheria toxin in gal4-de
131 selectively blocked by the expression of the tetanus toxin light chain subunit (TeNT), the regularity
132 naptically silenced by chronic expression of tetanus toxin light chain tagged with cyan fluorescent p
133 nergic neurons, we inactivated them with the tetanus toxin light chain, a genetically encoded inhibit
134                    Conditional expression of tetanus toxin light chain, a molecule that inhibits syna
135 , unc-1(dn) has effects opposite to those of tetanus toxin light chain, separating the roles of ADL e
136 aptic connectivity observed previously after tetanus toxin light chain-dependent blockade of evoked s
137 exocytosis as strongly as co-transfection of tetanus toxin light chain.
138 le-cell pairs demonstrated directly that the tetanus toxin-mediated block of exocytosis is accompanie
139                                    Moreover, tetanus toxin-mediated inactivation of Gr66a- or Gr5a-ex
140                                              Tetanus toxin-mediated inactivation of Gr68a-expressing
141                                       In the tetanus toxin model of limbic epilepsy, rats have interm
142 dorant stimuli, optogenetics, and transgenic tetanus toxin neurotransmission block show that elevated
143 thesized with two universal Th epitopes from tetanus toxin (p2p30).
144                                              Tetanus toxin produces spastic paralysis in situ by bloc
145 p53, HER2-ICD, HER2-ECD, and CEA, but not to tetanus toxin, relative to controls and surgically resec
146              The nontoxic fragment C (HC) of tetanus toxin retains the specific nerve cell binding an
147 th presynaptic vesicle fusion by exposure to tetanus toxin reverted functional to silent transmission
148 ross the nanotube, a membrane-bound protein (tetanus toxin) sees the nanotube as a barrier.
149 ced inhibition of early endosome fusion in a tetanus toxin-sensitive manner and removes Hrs from earl
150 rminus or carboxyl terminus of fragment C of tetanus toxin, separated by a 4-amino-acid hinge region.
151 ed by all subjects: one largely overlapped a tetanus toxin sequence region previously identified as a
152 hetic peptides corresponding to the complete tetanus toxin sequence were used to test, in a prolifera
153           Eight weeks after the injection of tetanus toxin, significantly more "dye-coupled' cells we
154 ',N'-tetraacetic acid, or the SNARE blocker, tetanus toxin, suggesting Ca2+- and SNARE-dependent fusi
155                                              Tetanus toxin suppressed EPSCs but did not influence OT-
156 copies of a PySSP2 sequence, NPNEPS, and two tetanus toxin T helper epitopes in the adjuvant TiterMax
157            Botulinum neurotoxins (BoNTs) and tetanus toxin (TeNT) are the most potent toxins for huma
158                       Cleavage of VAMP2 with tetanus toxin (TeNT) did not prevent delivery of TRPC3 t
159                                              Tetanus toxin (TeNT) elicits spastic paralysis through t
160 n by different neuronal subtypes, we express tetanus toxin (TeNT) in individual reticulospinal or CoP
161 types of bipolar cells in the retina express tetanus toxin (TeNT).
162 man GDNF to the neuronal binding fragment of tetanus toxin (tetanus toxin fragment C, or TTC).
163     The non-toxic neuronal binding domain of tetanus toxin (tetanus toxin fragment C, TTC) has been u
164 pressing an unrelated antigen (fragment C of tetanus toxin [TetC]) was also used for immunization as
165                                              Tetanus toxin (TeTx) causes sympathetic hyperactivity, a
166              Six rats received injections of tetanus toxin (TeTX) in the ventral hippocampus that res
167  the basis of these analyses, two regions in tetanus toxin that are structurally homologous with the
168 s a non-toxic 47 kDa polypeptide fragment of tetanus toxin that can be used as a subunit vaccine agai
169   Although di- and trisialogangliosides bind tetanus toxin, their role as productive toxin receptors
170 gliosides completely restores the ability of tetanus toxin to bind to the neuronal surface and to blo
171 ion and postsynaptic specialization, we used tetanus toxin to chronically cleave VAMP2 and inhibit SN
172                                Expression of tetanus toxin to cleave VAMP2 in VAMP8 knock-out (-/-) a
173 ely, blocking glutamate release by targeting tetanus toxin to individual synapses increases alpha7-nA
174 f the carboxy-terminal 50 kDa HC fragment of tetanus toxin to polysialogangliosides is important for
175 nditional expression of the light chain from tetanus toxin (tox) in raphe neurons expressing serotone
176 , the motor cortex of rats was injected with tetanus toxin (TT), and gene expression for 67 kDa gluta
177 e separated following rosette formation with tetanus toxin (TT)-coupled immunobeads to study the regu
178 tigated in chronic focal epilepsy induced by tetanus toxin (TT, 20-35 ng) injected in the rat motor c
179 theria toxin (DTx) followed by fragment C of tetanus toxin (TTC).
180       This analysis provides a model for how tetanus toxin utilizes coreceptors for high-affinity bin
181          The gene encoding the C fragment of tetanus toxin was expressed in the aroAD mutant of S. ty
182                         On postnatal day 10, tetanus toxin was unilaterally injected into the hippoca
183 of Ca2+ influx, but in a manner sensitive to tetanus toxin, we find that the secretory process is dir
184 or fused to a fragment C (FrC) sequence from tetanus toxin, we induced both anti-Id and anti-FrC anti
185 /C entered cells differently than the HCR of tetanus toxin, which also utilizes dual gangliosides as
186 tion process is the v-SNARE, VAMP-2, because tetanus toxin, which cleaves VAMP-2, inhibited the forma
187 ion of the receptor binding domain (H(C)) of tetanus toxin, which retains the binding and trafficking
188 rface protein 1 and two T-helper epitopes of tetanus toxin (yP2P30Pv20019), formulated in aluminum hy

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top